2024-09-03 - Analysis Report
## UNH Stock Analysis Report

This report provides a comprehensive analysis of UnitedHealth Group (UNH), a leading health insurance and health care services company, based on the provided data.

**1. Performance Comparison:**

* **Company Overview:** UnitedHealth Group (UNH) is a diversified health and well-being company that offers a wide range of health insurance plans, health care services, and related products. 
* **Cumulative Return:** UNH has exhibited a cumulative return of 104.69%, outperforming the S&P 500 (VOO) which has a cumulative return of 89.66%. 
* **Relative Strength:** The current relative strength of UNH against the S&P 500 is 15.03, indicating that UNH has outperformed the benchmark index. This represents a 43.78% relative strength position based on the historical range of -23.3 to 65.6.

**2. Recent Price Movement:**

* **Closing Price:** $590.2
* **Moving Averages:**
    * 5-day: $588.96
    * 20-day: $577.57
    * 60-day: $538.91

UNH's current price is slightly above its 5-day moving average, suggesting a recent upward trend. However, the 20-day and 60-day moving averages are below the current price, hinting at a potential short-term upward momentum and longer-term consolidation.

**3. Technical Indicators:**

* **RSI (Relative Strength Index):** 83.85
* **PPO (Percentage Price Oscillator):** -0.12
* **Delta_Previous_Relative_Divergence:** -10.56 (indicating a recent short-term downward trend)
* **Expected_Return:** 38.82% (estimated maximum 5-year return on current investment)

The high RSI value indicates that UNH is currently in overbought territory, potentially signaling a potential correction. A negative PPO value suggests that the stock price is declining compared to its 20-day and 12-day moving averages, confirming a short-term downward trend. However, the relatively high expected return suggests a potential long-term growth opportunity.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-09 | 4.58 | 98.86 B$ |
| 2024-05-09 | -1.53 | 99.80 B$ |
| 2023-11-06 | 6.31 | 92.36 B$ |
| 2023-08-02 | 5.89 | 92.90 B$ |
| 2024-08-09 | 5.89 | 92.90 B$ |

The most recent earnings report for Q2 2024 showed EPS of 4.58, exceeding analyst expectations. Revenue for the quarter reached 98.86 billion dollars, indicating strong growth and consistent performance. This positive trend in earnings reflects the company's robust position in the healthcare market and its ability to manage costs effectively.

**5. Comprehensive Analysis:**

UNH has consistently outperformed the S&P 500, demonstrating strong growth and profitability. While the recent technical indicators suggest a short-term downward trend, the positive earnings performance and long-term growth potential remain attractive. The high expected return further strengthens the bullish outlook for UNH. However, the current overbought condition suggests a potential correction in the short term. 

**6. Conclusion:**

Based on the analysis, UNH remains a strong investment opportunity with a track record of consistent growth and profitability. While short-term corrections may occur, the long-term outlook remains positive. Investors should monitor the stock closely, particularly the technical indicators, and adjust their positions accordingly. 
